TransMedics (TMDX) Equity Ratio (2018 - 2026)

TransMedics' Equity Ratio history runs 9 years deep, the most recent figure standing at 0.34 for Q1 2026.

• In Q1 2026, Equity Ratio rose 8.28% year-over-year to 0.34; the TTM figure through Mar 2026 stood at 0.34 (up 8.28% YoY), while the FY2025 annual figure was 0.44, up 55.76% from the prior year.
• Equity Ratio was 0.34 for Q1 2026 at TransMedics, down from 0.44 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.68 in Q3 2022 to a low of 0.18 in Q3 2023.
• Historically, Equity Ratio has averaged 0.38 across 5 years, with a median of 0.34 in 2026.
• The sharpest annual moves came in 2023 and 2025: Equity Ratio slumped 73.15% in 2023, then soared 55.76% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.68 in 2022, then slumped by 71.26% to 0.19 in 2023, then soared by 46.3% to 0.28 in 2024, then surged by 55.76% to 0.44 in 2025, then dropped by 22.25% to 0.34 in 2026.
• The last three Equity Ratio figures came in at 0.34 (Q1 2026), 0.44 (Q4 2025), and 0.38 (Q3 2025), per Business Quant data.